drugset
drugset / Trial / NCT03223350

Topical Capsaicin for Cyclical Vomiting

NCT03223350 ↗

Phase 2 Completed 30 enrolled Henry Ford Health System
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This is a phase 2 randomized controlled trial testing the effect of topical capsaicin for the relieve of nausea and vomiting.

Timeline

Start
2017-12-20
Primary completion
2019-08-05
Completion
2019-08-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Capsaicin Small molecule 0.1 % Topical

Indications

cyclic vomiting syndrome